Experimental Primary Biliary Cholangitis (PBC) |
Xenobiotic induced PBC in Gal-3 deficient mice |
Protective |
Gal-3 protects biliary epithelial cells from apoptosis and thus attenuates autoantigen release |
[148] |
Novosphingobium aromaticivorans induced PBC in Gal-3 deficient mice |
Proinflammatory |
Gal-3 is necessary for the activation of NLRP3 inflammasome in liver macrophages and subsequent IL-17 mediated inflammatory process |
[155] |
Spontaneously developed autoimmune cholangitis in dnTGF-βRII mice and Gal-3 deficient mice |
Proinflammatory |
Gal-3 is an initiator of inflammatory signaling and mediation of the activation of NLRP3 inflammasome and IL-17 proinflammatory cascades |
[151] |
Experimental Hepatitis |
MCMV induced hepatitis Gal-3 deficient mice |
Antiinflammatory, protective |
Gal-3 attenuates TNF-α-mediated death of hepatocytes |
[162] |
α-galactosylceramide induced hepatitis in Gal-3 deficient mice |
Proinflammatory |
Gal-3 regulates the capacity of DCs to support NKT-cell-mediated liver injury |
[163] |
Con A-induced hepatitis in Gal-3 deficient mice and Gal-3 inhibitor treated mice |
Proinflammatory |
Gal-3 promotes the influx of mononuclear cells and proinflammatory CD4+ cells in the liver and decreases influx of IL-10 expressing CD4+ T cells and F4/80+ macrophages |
[164] |
Experimental Non-Alcoholic Fatty Liver Disease |
High-fat diet nonalcoholic steatohepatitis induced in Gal-3 deficient mice |
Proinflammatory |
Gal-3 increases hepatic accumulation of advanced lipoxidation endproducts, up-regulates lipid synthesis and oxidation causing more fat deposition, oxidative stress, and inflammation |
[165] |
High-fat diet induced steatohepatitis and liver steatosis in Gal-3 deficient mice |
Proinflammatory |
Increased mRNA expression of CCL2, F4/80, CD11c, TLR4, CD14, NLRP3 inflammasome, IL-1β, IL-13 and IL-33 in the liver |
[166] |
Experimental Hepatocellular Carcinoma |
N-diethylnitrosamine induced hepatocellular carcinoma in Gal-3 deficient mice |
Pro-tumor effects |
Gal-3 promotes motility and invasion of hepatoma cells by an autocrine pathway |
[167] |